More than half of healthcare and life sciences organizations in the Asia-Pacific are planning to have dedicated budgets for generative artificial intelligence (GenAI) projects for timely investments.
According to a recent IDC report, GenAI in Healthcare and Life Sciences: Current Trends and Future Potential in Asia/Pacific, the Asia-Pacific is set to be the fastest-growing region in healthcare and life sciences GenAI spending.
This IDC report delves deeper into the current GenAI adoption trends, focus areas, organizational challenges, and preferred vendor attributes by healthcare and life sciences organizations in Asia-Pacific.
The report also provides a dashboard view of the use cases sourced from the IDC GenAI Taxonomy report and maps these use cases with specific case studies by major healthcare providers and life sciences organizations.
The report also features tech providers covered in the case studies by detailing their unique GenAI capabilities and offerings.
IDC report highlights
Other highlights of the report include: 77% of healthcare and 53% of life sciences organizations in Asia-Pacific are focusing on proofs of concepts (POCs) and use case identification for GenAI projects; Asia-Pacific will be the fastest growing region in healthcare GenAI spending, accounting for around 15% of the global spending by 2027; Regulatory risks and higher infrastructure costs are the topmost limiting factors for GenAI adoption in healthcare organizations; and robust data security capability and intuitive AI models are the topmost capabilities CIOs look for in a software provider to develop GenAI solutions.
“GenAI adoption in healthcare and life sciences, though at its nascent stage, is set to have a significant impact on enhancing clinician efficiency, improving workflow productivity, and hyperpersonalization of patient experience. Currently, there is increased priority towards POCs as part of GenAI model deployments, this is set to transition to full-fledged deployments supported by matured clinical data sets, regulatory support, enhanced skill sets, and alignment of GenAI use cases with organizational priorities,” Manoj Vallikkat, Senior Research Manager, Health Insights, Asia/Pacific, said. For more information on this IDC document, please contact Manoj Vallikkat at mvallikkat@idc.com. For media inquiries, please contact Miguel Carreon at mcarreon@idc.com or Michael de la Cruz at mdelacruz@idc.com.
